Manufacturing

WuXi Biologics signed letter of intent for long-term vaccine manufacturing contract

WuXi Biologics, a global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, announced that it has entered into a strategic partnership letter of intent (LOI) with a global vaccine leader, pursuant to which WuXi Vaccines will build a dedicated facility and supply a commercial product for the global market.

Catalent wraps up $1.2bn acquisition of gene therapy CDMO Paragon

Catalent has wrapped up its $1.2bn acquisition of Maryland-based gene therapy contract development and manufacturing organisation (CDMO) Paragon Bioservices.

Thermo Fisher Scientific to acquire manufacturing site in Cork, Ireland, from GSK

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced today that it has entered into a definitive agreement to acquire a drug substance manufacturing site in Cork, Ireland, from GlaxoSmithKline plc (NYSE: GSK) for approximately €90 million in cash.

Pfizer opens new biologics clinical manufacturing facility in Massachusetts

Pfizer has announced the opening of a new 175,000 square-foot manufacturing facility in Andover, Massachusetts.

Kite announces plans for new state-of-the-art facility to expand cell therapy production capabilities

Kite, a Gilead Company (Nasdaq: GILD), today announced plans for a new facility in Frederick County, Maryland, which will produce innovative cell therapies for people with cancer.

GSK invests $100m to boost vaccine manufacturing at US facility

British drugmaker GlaxoSmithKline (GSK) is set to invest $100m to expand long-term vaccine manufacturing capabilities at its Hamilton facility in Montana, US.

Lilly announces sale of legacy antibiotics brands and manufacturing facility in China

Eli Lilly and Company (NYSE: LLY) today announced that it has entered into an agreement to sell the rights in China for two legacy Lilly antibiotic medicines, Ceclor and Vancocin, as well as a manufacturing facility in Suzhou, China that produces Ceclor, to Eddingpharm, a China-based specialty pharmaceutical company.

MS Pharma to acquire European pharmaceutical firm Genepharm

Jordan-based MS Pharma has agreed to acquire European pharmaceutical firm, Genepharm, for an undisclosed sum.

Sun Pharma launches ready-to-infuse INFUGEM in the US

Sun Pharmaceutical Industries Ltd. announced that INFUGEM (gemcitabine in sodium chloride injection), for intravenous use, is now commercially available in the U.S.